MUC1 vaccine in patients with newly diagnosed advanced adenomas

Ended Awarded Last action

Contract number
HHSN26100003
Awardee
Awarding agency
Obligated
$915,331

Award facts

Opportunity
  • N01CN0501469 Solicitation number
Contract value 100% obligated
$915,330.83 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
PSC
AN12 Health R&D Services; Health Care Services; Applied Research
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Cost No Fee
Place of performance
Rochester, MN 55905, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00009 -$22,553
Funding Only Action 8 -$105,532
Funding Only Action 7 $0
Other Administrative Action 6 $0
Funding Only Action 5 $100,924
Supplemental Agreement for work within scope 4 $0
Other Administrative Action 3 $3,040
Other Administrative Action 2 $0
Change Order 1 $0
Original award $939,452

Quick answers

Who was awarded contract HHSN26100003?

HHSN26100003 was awarded to Mayo Clinic by National Cancer Institute (National Institutes of Health) on September 6, 2013.

How much is contract HHSN26100003 worth?

The government has obligated $915,331 on HHSN26100003.

Is contract HHSN26100003 an order under another contract?

Yes. HHSN26100003 is a delivery order under HHSN261201200042I, an indefinite delivery contract.

Was contract HHSN26100003 competed?

The extent of competition for HHSN26100003 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login